152 related articles for article (PubMed ID: 36057744)
1. Effect of Topical Antifungal Luliconazole on Hyphal Morphology of Trichophyton mentagrophytes Grown on in vitro Onychomycosis Model.
Nishiyama Y; Maeda M; Yamada T
Mycopathologia; 2022 Dec; 187(5-6):491-496. PubMed ID: 36057744
[TBL] [Abstract][Full Text] [Related]
2. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
Shimamura T; Hasegawa N; Kubota N
Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
[TBL] [Abstract][Full Text] [Related]
4. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
Scher RK; Nakamura N; Tavakkol A
Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
[TBL] [Abstract][Full Text] [Related]
5. A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
Nakamura A; Hirakawa S; Nagai H; Inagaki K
Med Mycol; 2021 Mar; 59(3):289-295. PubMed ID: 33539539
[TBL] [Abstract][Full Text] [Related]
6. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution].
Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N
Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
9. Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro.
Nakashima T; Nozawa A; Ito T; Majima T
J Infect Chemother; 2002 Dec; 8(4):331-5. PubMed ID: 12525893
[TBL] [Abstract][Full Text] [Related]
10. Luliconazole Nail Lacquer for the Treatment of Onychomycosis: Formulation, Characterization and In Vitro and Ex Vivo Evaluation.
Dehari D; Mehata AK; Priya V; Parbat D; Kumar D; Srivastava AK; Singh S; Agrawal AK
AAPS PharmSciTech; 2022 Jun; 23(6):175. PubMed ID: 35750993
[TBL] [Abstract][Full Text] [Related]
11. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
[TBL] [Abstract][Full Text] [Related]
12. Novel in vivo observations on double acting points of luliconazole on Trichophyton rubrum: an ultrastructural study.
Wakumoto-Nakashima K; Yamada N; Morino S; Yamamoto O
Med Mycol; 2015 Nov; 53(8):860-7. PubMed ID: 26316213
[TBL] [Abstract][Full Text] [Related]
13. A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
Masumoto A; Takagi M; Sugiura K; Matsuda Y; Nakamura S; Tatsumi Y
J Mycol Med; 2022 Aug; 32(3):101259. PubMed ID: 35255449
[TBL] [Abstract][Full Text] [Related]
14. A Case of Nail Yellow Discoloration due to Topical Treatment of Onychomycosis with Luliconazole 5% Nail Solution.
Sato T; Fukada N; Kinjo A; Akimoto R; Kobayashi H; Fukuzumi S
Med Mycol J; 2023; 64(2):45-47. PubMed ID: 37258134
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
[TBL] [Abstract][Full Text] [Related]
16. [In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
Maeda J; Nanjoh Y; Koga H; Toga T; Makimura K; Tsuboi R
Med Mycol J; 2016; 57(1):J1-6. PubMed ID: 26936346
[TBL] [Abstract][Full Text] [Related]
17. The effect of bifonazole on the structure of Trichophyton.
Osumi M; Yamada N; Okada J; Yamaguchi H; Hiratani T; Plempel M
Arzneimittelforschung; 1983; 33(10):1484-91. PubMed ID: 6686051
[TBL] [Abstract][Full Text] [Related]
18. [Affinity of Luliconazole to Keratin Prepared from Healthy Human Nailand Porcine Hoof].
Hasuko M; Toga T; Tsunemitsu T; Matsumoto T; Koga H; Hirano H; Tsuboi R
Med Mycol J; 2016; 57(1):J7-12. PubMed ID: 26936352
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activities of luliconazole, a new topical imidazole.
Koga H; Nanjoh Y; Makimura K; Tsuboi R
Med Mycol; 2009; 47(6):640-7. PubMed ID: 19115136
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.
Koga H; Tsuji Y; Inoue K; Kanai K; Majima T; Kasai T; Uchida K; Yamaguchi H
J Infect Chemother; 2006 Jun; 12(3):163-5. PubMed ID: 16826352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
